Collaboration
Tolero Pharmaceuticals Announces Clinical Research Collaboration with AbbVie for Acute Myeloid Leukemia Trial
Tolero Pharmaceuticals
PR-M09-18-NI-071Sep 24, 2018
Advanced Solid Tumors
Tolero Pharmaceuticals Announces First Patient Dosed with Investigational Agent TP-0184 in Phase 1 Study of Patients with Advanced Solid Tumors
Tolero Pharmaceuticals
PR-M07-18-NI-096Jul 27, 2018
Preclinical Data
Tolero Pharmaceuticals to Present Preclinical Data Supporting Apoptosis-Inducing Activity of Alvocidib in Acute Myeloid Leukemia
Tolero Pharmaceuticals
PR-M04-18-NI-56Apr 17, 2018